ORBIMED ADVISORS LLC Insider Trading $ATHX ATHERSYS, INC / NEW
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is Director in INSULET CORP ($PODD) and 10% Owner in CRYOCOR INC ($CRYO) and Director in CRYOCOR INC ($CRYO) and 10% Owner in Anthera Pharmaceuticals Inc ($ANTH) and Director in Biodel Inc ($BIOD) and Director in NxStage Medical, Inc. ($NXTM) and Director in ATHERSYS, INC / NEW ($ATHX) and 10% Owner in ARYx Therapeutics, Inc. ($ARYX) and Director in ARYx Therapeutics, Inc. ($ARYX).
ORBIMED ADVISORS LLC in ATHERSYS, INC / NEW
Trading Symbol: ATHXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,805,100 shares
Current Value: $2,093,916
Latest Transaction: Jan 12 2010
$ATHX Market Capitalization: $97.47M
$ATHX Previous Close: $1.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in ATHERSYS, INC / NEW
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALBO, ANTH, ARYX, ATHX, CRYO, PODD, NXTM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 12 2010 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Sell | J | 0.00 | 4,947 | 0 | 1,805,100 | 1.8 M to 1.8 M (-0.27 %) |
Jan 12 2010 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Sell | J | 0.00 | 1,800,153 | 0 | 1,810,047 | 3.6 M to 1.8 M (-49.86 %) |
Mar 18 2009 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 0.84 | 110,000 | 92,400 | 3,610,200 | 3.5 M to 3.6 M (+3.14 %) |
Mar 18 2009 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 0.65 | 52,200 | 33,930 | 3,500,200 | 3.4 M to 3.5 M (+1.51 %) |
May 23 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 6.00 | 750,000 | 4,500,000 | 750,000 | |
May 23 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 5.00 | 75,000 | 375,000 | 75,000 | |
May 23 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 2.40 | 268,000 | 643,200 | 3,448,000 | 3.2 M to 3.4 M (+8.43 %) |
May 21 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 6.00 | 750,000 | 4,500,000 | 750,000 | |
May 21 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 5.00 | 75,000 | 375,000 | 75,000 | |
May 21 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 2.40 | 130,000 | 312,000 | 3,180,000 | 3.1 M to 3.2 M (+4.26 %) |
May 15 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 6.00 | 750,000 | 4,500,000 | 750,000 | |
May 15 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 5.00 | 75,000 | 375,000 | 75,000 | |
May 15 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 2.40 | 50,000 | 120,000 | 3,050,000 | 3 M to 3.1 M (+1.67 %) |
Jun 12 2007 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 6.00 | 750,000 | 4,500,000 | 750,000 | |
Jun 12 2007 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 5.00 | 75,000 | 375,000 | 75,000 | |
Jun 12 2007 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 5.00 | 3,000,000 | 15,000,000 | 3,000,000 | 0 to 3 M |
Page: 1